D-Wave Quantum: A Fortune 100 Bet and a University Sale — But the Stock’s Next Move Hinges on a Cent-Wide Support Line

D-Wave Quantum used its Investor Day to unveil a pair of high-profile commercial wins that underscore its claim to being the most revenue-active player in the quantum computing space. A Fortune 100 conglomerate has signed a ten-year framework agreement, with the first two years committed to Quantum-Computing-as-a-Service worth $10 million. Separately, the company booked a $20 million system sale to Florida Atlantic University. The cabinet is stacking up, and management sketched out a vision where its existing cloud infrastructure — four systems running in parallel — could generate between $100 million and $120 million annually in QCaaS revenue. That forward-looking projection is far from a guarantee, but it maps a trajectory that the market has been slow to price in.

Yet the same stock that just scooped up a Fortune 100 client closed the previous Friday at €20.71, down 17.5% in a single week — a rout triggered by a broader Nasdaq pullback and persistent doubts about the quantum investment thesis. The Monday session brought a modest recovery to €21.16, leaving shares roughly 16% below their level a week earlier. Over a 30-day horizon the equity still shows a 7.9% gain, and over twelve months it has climbed nearly 30%. That contradictory picture — commercial momentum against a sharp weekly decline — defines the current tension around D-Wave.

At €21.16, the stock is barely 2% above its 200-day moving average of roughly €20.74. The secondary article pegged that line at €20.70, meaning the Friday close was within a cent of it. The relative strength index sits near 49.8 (or 48.5 by the other calculation), squarely in neutral territory — no overheating, no capitulation. The 50-day average at €17.90 lies more than 15% below the current price, so the intermediate trend is still intact. What makes this technical setup volatile is the annualized price swing of nearly 138%. At that level of noise, narratives outrace fundamentals.

The deeper debate hanging over D-Wave concerns the credibility of its quantum supremacy claim. The company has pushed back forcefully against suggestions that classical simulations have invalidated its peer-reviewed results. D-Wave argues that the newer classical methods, while notable advances, have not replicated the hardest cases or the full measurement set from its published work. This is not an academic side-show: the stock’s valuation is built on the premise that certain problem classes will eventually require specialized quantum infrastructure. If classical approaches continue to close the gap, the investment case shrinks. If D-Wave can defend specific categories where classical replication is genuinely difficult, the “proof premium” remains. The current price action — 46% below the 52-week high of €38.48 but still 86% above the year’s low of €11.12 — captures a narrative that is alive but under constant pressure.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Part of the reason the story stays alive is government backing. D-Wave has signed a letter of intent with the U.S. Department of Commerce under the CHIPS and Science Act that could channel up to $100 million into accelerating the company’s development and scaling. That funding, drawn from a $2 billion quantum-research pool, sent shares 49% higher in May when it was announced. The government is increasingly treating quantum capability as strategic infrastructure, not venture-capital experimentation. With a market capitalisation of €7.67 billion, D-Wave is already being priced as more than a lab project.

Rosenblatt sees the fair value at $43 a share, more than double the current dollar equivalent. Technical analysts point to a medium-term target zone between $45 and $46 as long as the stock holds above the €20-to-€22 range. But the competitive field is thickening: Quantinuum debuted on the Nasdaq on June 4, and Microsoft unveiled its “Majorana 2” quantum processor. The sector is growing more crowded, and D-Wave’s lead as the most commercially active provider will face sharper scrutiny when next quarter’s results land.

The company is trying to shift the conversation from abstract superiority claims to repeatable business workloads. A D-Wave-sponsored report on the U.K. market describes large corporations moving from theoretical exploration to practical application. EY research highlights banks, payment processors and auto manufacturers testing quantum for fraud detection, battery development and traffic flow. Not every experiment ends in a contract, but the language has moved from the laboratory to the operating budget. D-Wave also plans a user conference in London to showcase organizations already deploying the technology across business, science and government.

That transition — from promise to infrastructure — will be the real test. The consensus price target of €31.62 still implies roughly 53% upside, so expectations have not evaporated. But last week’s 17.5% decline shows how quickly the market punishes a stock when conviction runs ahead of evidence. D-Wave now sits on a technical line that is literally a cent wide, with a commercial pipeline that is genuinely thickening and a volatility profile that can amplify either outcome. The next phase will be measured not by roadmaps, but by how many customers are willing to write cheques that big for a machine that still has to prove its indispensability.